Kelly Osbourne says she will have the same surgery as Angelina Jolie

She explained she will have her ovaries removed after testing positive for the same cancer-causing BRCA1 gene.

Yesterday, Kelly Osbourne opened up to US chat show The Talk to reveal that she plans to have her ovaries removed in the future after testing positive to the same cancer-causing BRCA1 gene that Angelina Jolie carries.

"I actually do have the cancer gene," Kelly said explaining that her mum Sharon Osbourne made sure the family was tested after her own cancer diagnosis back in 2012.

Kelly’s revelation comes after news that Angelina Jolie decided to have her ovaries removed following her preventive double mastectomy. In the piece for the New York Times, Angelina writes:

"I did not do this solely because I carry the BRCA1 gene mutation, and I want other women to hear this. A positive BRCA test does not mean a leap to surgery. I have spoken to many doctors, surgeons and naturopaths. There are other options.

"Some women take birth control pills or rely on alternative medicines combined with frequent checks. There is more than one way to deal with any health issue. The most important thing is to learn about the options and choose what is right for you personally."

Kelly also says she fully supports Angelina’s decision and would be following her lead "100 per cent".

"I will eventually have to do it too because if I have children, I want to be there to bring them up. I want to be there to support them in every way I can," Kelly said.

"I have been the child of a cancer survivor, so being on that end as well is really, really hard to deal with, so I'm so lucky to have the brave mother I have that has taught me so much."

Kelly also referenced the media attention Angelina’s story has received this week saying it’s really positive for cancer awareness. "It's something I applaud Angelina for because she's bringing attention to this, and people are now going to go out and get tested for it."

According to Cancer Australia, carrying the BRCA1 gene increases a woman's lifetime risk of developing breast and ovarian cancers to 65 per cent and 39 per cent as well as an increased risk of developing fallopian tube and peritoneal cancers. However, even if those carrying the gene do decide to undergo the surgery, it doesn’t entirely remove the risks of eventually developing cancer.